Medicine and Dentistry
Sarcopenia
99%
Patient
91%
Older Adult
86%
Health
63%
Mortality
61%
Age
58%
Association
51%
Multiple Chronic Conditions
48%
Nursing Home
45%
Assessment
44%
Person
40%
Down Syndrome
38%
Aging
33%
Resident
32%
Prevalence
31%
Adult
30%
Therapeutic Procedure
29%
Frailty
26%
Pain
26%
Polypharmacy
25%
Adverse Drug Reaction
24%
Survival
24%
Muscle
23%
Hazard Ratio
22%
Drug Therapy
21%
Chemotherapeutic Agent
21%
Elderly Patient
21%
Follow up
21%
Drug
20%
Chronic Disease
18%
Parasympatholytic
17%
Inpatient
17%
Disability
17%
Cognitive Defect
17%
Cholestasis
17%
Woman
17%
Medication
16%
Peroral Endoscopic Myotomy
15%
Deterioration
14%
Dementia
14%
Typical Antipsychotic
14%
Biological Marker
14%
Exercise
14%
Protein
14%
Physical Performance
13%
Geriatric Syndrome
13%
Telomere
13%
Cardiovascular System
13%
Stent
13%
Marker
13%
Nursing and Health Professions
Nursing Home
100%
Patient
81%
Resident
71%
Mortality
64%
Frailty
54%
Older Adult
41%
Drug Therapy
40%
Prevalence
38%
Multiple Chronic Conditions
33%
Hospitalization
31%
Older People
31%
Home Care
30%
Sarcopenia
27%
Polypharmacy
27%
Pain
26%
Person
26%
Confidence Interval
25%
Drug
25%
Procedures
22%
Death
22%
Cognitive Defect
21%
Depression
21%
Parkinson Disease
21%
Hospital
21%
Long Term Care
21%
Typical Antipsychotic
20%
Dementia
18%
Elderly Patient
18%
Vaccination Policy
17%
Immunization
17%
Caregiver
17%
Cholinergic Receptor Blocking Agent
17%
Adverse Drug Reaction
17%
Adult
15%
Ischemic Heart Disease
15%
Disability
14%
Survival
14%
Gender
13%
Sample
12%
Prescription
12%
Electric Potential
12%
Emergency Care
12%
Community Care
11%
Deterioration
11%
Devices
10%
Symptom
10%
Hearing Impairment
9%
Marker
9%
Comorbidity
9%
Systematic Review
9%
Pharmacology, Toxicology and Pharmaceutical Science
Drug
83%
Adverse Drug Reaction
73%
Polypharmacy
73%
Frailty
68%
Prevalence
45%
Mortality
45%
Multiple Chronic Conditions
35%
Cognitive Defect
30%
Sarcopenia
29%
Death
25%
Dementia
20%
Diseases
18%
Dipeptidyl Carboxypeptidase Inhibitor
17%
Cholinergic Receptor Blocking Agent
17%
Parkinson Disease
17%
Ischemic Heart Disease
15%
Chronic Disease
15%
Prescribing Drug
15%
Pain
13%
Depression
12%
Adverse Event
12%
Symptom
11%
Observational Study
11%
Prescription Drug
10%
Iatrogenic Disease
10%
Prescription Medication
10%
Survival
9%
All Cause Mortality
9%
Functional Status
9%
Disability
9%
Pharmacoepidemiology
9%
Comorbidity
9%
Safinamide
9%
Delirium
9%
Pharmacokinetics
9%
Confounder
9%
Incidence
8%
Biological Marker
8%
Heart Failure
7%
Atypical Antipsychotics
6%
Life Expectancy
5%
Osteoporosis
5%
Cholestasis
5%
Indicator
5%
Herbal Agent
5%
Drug-Drug Interaction
5%
Femur Fracture
5%
Drug Quality
5%
Stent
5%
Hip Fracture
5%
